Literature DB >> 30488579

Accuracy of fine-needle aspiration cytology of head and neck masses.

Soumaya Rammeh1,2, Emna Romdhane1,3, Asma Sassi1,2, Linda Belhajkacem1,2, Ahlem Blel1,2, Meriem Ksentini1,2, Rim Lahiani2,4, Faten Farah1,2, Mamia Ben Salah2,4, Mohamed Ferjaoui2,4.   

Abstract

BACKGROUND: Head and neck masses are a common presentation in daily practice and can be challenging to both clinicians and cytopathologists. Fine needle aspiration cytology (FNAC) is a widely used method for the diagnosis of head and neck masses. The aim of the study was to assess our institutional experience of the accuracy of FNAC in the diagnosis of head and neck masses.
METHODS: A total of 1262 FNACs were conducted from January 2013 to December 2016 and subdivided into benign and malignant categories. The thyroid and salivary glands FNACs were classified according to the Bethesda System for Reporting Thyroid cytopathology and to the Milan System for Reporting Salivary Gland Cytopathology respectively. The measures of diagnostic accuracy of FNAC were determined taking histology as a gold standard.
RESULTS: A total of 7 false negative (FN) and 6 false positive (FP) FNACs were identified. Overall sensitivity and specificity of FNAC for a malignant diagnosis were 92% and 94.4%, respectively. Accuracy of FNACs of head and neck masses was 93.5% for all sites. The salivary gland group had the highest rate of FN (2.8%). All FP were reported in the thyroid group. These cases were cytologically classified suspicious for malignancy (n = 3) and papillary carcinoma (n = 3) and proved to be lymphocytic thyroiditis on final histology. Among the most common locations, cytology of lymph nodes provided the best sensitivity (98.2%). Salivary glands as well as lymph nodes had the best specificity (100%).
CONCLUSION: FNAC of head and neck masses has a high accuracy allowing a correct therapeutic management. However, this accuracy depends on the anatomic location of the mass.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  fine needle aspiration cytology; head and neck; lymph node; salivary gland; thyroid gland

Mesh:

Year:  2018        PMID: 30488579     DOI: 10.1002/dc.24120

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

1.  [Ultrasound-guided minimally invasive diagnostics and treatment in the head and neck area].

Authors:  A Bozzato; C Neubert; Y Yeter
Journal:  HNO       Date:  2021-02       Impact factor: 1.284

2.  Effects of COVID-19 pandemic on cytology: specimen adequacy in fine-needle aspiration of palpable head and neck masses.

Authors:  Kimmie Rabe; Aastha Chauhan; Jana Holler; Tetyana Mettler; Khalid Amin; Jimmie Stewart
Journal:  J Am Soc Cytopathol       Date:  2022-04-19

3.  Milan System for Reporting Salivary Gland Cytopathology- An Experience from Western Indian Population.

Authors:  Vaishali P Gaikwad; Chanda Anupriya; Leena P Naik
Journal:  J Cytol       Date:  2020-04-02       Impact factor: 1.000

4.  A Nomogram to Predict the Outcome of Fine Needle Aspiration Cytology in Head and Neck Masses.

Authors:  Ulana Kotowski; Faris F Brkic; Oskar Koperek; Eleonore Pablik; Stefan Grasl; Matthaeus Ch Grasl; Boban M Erovic
Journal:  J Clin Med       Date:  2019-11-22       Impact factor: 4.241

5.  Comparative study on the diagnostic value of intravenous/peritumoral injection of indocyanine green for metastatic lymph node location in patients with head and neck squamous cell carcinoma (HNSCC).

Authors:  Chengwan Xia; Qunzhi Zhou; Qian Zhang; Shiqi Hu; Elisa Meacci; Yosuke Matsuura; Marion Durand; Qingang Hu; Huiming Cai; Yuxin Wang
Journal:  Ann Transl Med       Date:  2021-03

Review 6.  Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era.

Authors:  Francisco J Civantos; Jan B Vermorken; Jatin P Shah; Alessandra Rinaldo; Carlos Suárez; Luiz P Kowalski; Juan P Rodrigo; Kerry Olsen; Primoz Strojan; Antti A Mäkitie; Robert P Takes; Remco de Bree; June Corry; Vinidh Paleri; Ashok R Shaha; Dana M Hartl; William Mendenhall; Cesare Piazza; Michael Hinni; K Thomas Robbins; Ng Wai Tong; Alvaro Sanabria; Andres Coca-Pelaz; Johannes A Langendijk; Juan Hernandez-Prera; Alfio Ferlito
Journal:  Front Oncol       Date:  2020-11-10       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.